The top priority in the field of analytical instruments, the primary position of independent control in the life science industry chain
Scientific research and analysis instruments are an important cornerstone of the life sciences and pharmaceutical and medical industries. Among them, mass spectrometers are one of the main fields with the largest market share, the most expensive average price and the highest technical barriers. In 2021, the global mass spectrometry market will be about 45 billion yuan. The global mass spectrometer market size can reach 70 billion yuan. In 2021, the domestic mass spectrometer market will be about 15 billion yuan, accounting for 30% of the global market, and the localization rate will be about 10%. The mass spectrometer has the properties of high throughput, high sensitivity and high resolution, and has established a leading position in detection applications in life science, medicine, semiconductor, environmental protection, food and other fields. position.
After 20 years of research and development, the rise of domestic power in mass spectrometry is at the time
The “14th Five-Year Plan”, the relevant policies of the Ministry of Science and Technology, and the Ministry of Industry and Information Technology all point out that the supply chain equipment needs to be stable and controllable, and the rigid domestic procurement ratio of instruments is specified to accelerate the process of import substitution of domestic mass spectrometers. Judging from the data from 2019 to 2022, the proportion of Chinese-made government procurement projects has steadily increased, covering liquid chromatography tandem triple quadrupole mass spectrometry, gas chromatography tandem mass spectrometry, etc. The domestic replacement of mass spectrometers is accelerating. Leading domestic mass spectrometer companies have integrated multiple resources from the government and scientific research institutions, and have been deeply engaged in the research and development of mass spectrometers for 20 years, accumulating patented technologies and talents in various disciplines, from the independent control of core components to the research and development of high-end mass spectrometers, and gradually promoting domestic replacement of mass spectrometers. Launched independent products in the fields of ICP-MS, LC-MS/MS, and GC-MS, and pushed forward the next R&D cycle in high-end directions such as ultra-high-resolution tandem mass spectrometry.
The mass spectrometer market has diversified penetration, and the market space is considerable
The US scientific research and biomedical medical mass spectrometer market accounts for about 70%. Due to the objective gap in the downstream industry standards and market space in the domestic benchmarking field, there is still a large space for the penetration of the application side. The stock market in the field of semiconductor environmental protection is superimposed. In the future The market share of domestic mass spectrometry can be expected. With the diversified penetration of mass spectrometry applications in the pharmaceutical industry, medical testing and diagnosis industry, and scientific research institutes, the corresponding mass spectrometer market is expected to reach 13.5 billion yuan in 2026, and the domestic mass spectrometer market is expected to reach 24 billion yuan in addition to other tracks. Emerging fields such as mass flow cytometry are expected to bring more room for growth to the mass spectrometry market.
To view the full report click here
Note: The articles on this site have not been posted and shared by netizens or institutions unless they are marked as original. If there is any need for publicity or infringement, please contact [email protected].
This article is reprinted from: https://www.dx2025.com/archives/170019.html
This site is for inclusion only, and the copyright belongs to the original author.